Anti-CD142 antibody(DMC463), IgG1 Chimeric mAb-抗体-抗体-生物在线
缔码生物科技(武汉)有限公司
Anti-CD142 antibody(DMC463), IgG1 Chimeric mAb

Anti-CD142 antibody(DMC463), IgG1 Chimeric mAb

商家询价

产品名称: Anti-CD142 antibody(DMC463), IgG1 Chimeric mAb

英文名称: Anti-CD142 antibody(DMC463), IgG1 Chimeric mAb

产品编号: DMC100463

产品价格: null

产品产地: China

品牌商标: DIMA Biotech

更新时间: null

使用范围:

缔码生物科技(武汉)有限公司
  • 联系人 :
  • 地址 : 武汉市洪山区东湖高新区高新大道666号光谷生物城B7
  • 邮编 : 430070
  • 所在区域 : 湖北
  • 电话 : 151****5168 点击查看
  • 传真 : 点击查看
  • 邮箱 : cygao@dimabio.com

This gene encodes coagulation factor III which is a cell surface glycoprotein. This factor enables cells to initiate the blood coagulation cascades, and it functions as the high-affinity receptor for the coagulation factor VII. The resulting complex provides a catalytic event that is responsible for initiation of the coagulation protease cascades by specific limited proteolysis. Unlike the other cofactors of these protease cascades, which circulate as nonfunctional precursors, this factor is a potent initiator that is fully functional when expressed on cell surfaces, for example, on monocytes. There are 3 distinct domains of this factor: extracellular, transmembrane, and cytoplasmic. Platelets and monocytes have been shown to express this coagulation factor under procoagulatory and proinflammatory stimuli, and a major role in HIV-associated coagulopathy has been described. Platelet-dependent monocyte expression of coagulation factor III has been described to be associated with Coronavirus Disease 2019 (COVID-19) severity and mortality. This protein is the only one in the coagulation pathway for which a congenital deficiency has not been described. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Aug 2020]